Epix Pharma Appoints Gamzu CEO

Xconomy Boston — 

The board of Epix Pharmaceuticals (NASDAQ:EPIX) has appointed Elkan Gamzu to be its CEO, after the 35-year life sciences industry veteran served as interim chief executive beginning last summer, according to the company. Gamzu, 66, took over the CEO role at Lexington, MA-based Epix vacated by former Epix CEO Michael Kauffman, who resigned in July 2008 after a series of clinical and regulatory setbacks at the firm during his two-year tenure.